Norikazu Masuda
- Oncology top 0.1%
- Pulmonary and Respiratory Medicine top 0.1%
- Cancer Research top 0.1%
- Molecular Biology top 2%
- Genetics top 1%
- Co-authors
- Seock‐Ah ImHiroji IwataPierfranco ContéBinghe XuMark E. RobsonSuzette DelalogeElżbieta SenkusAnne Armstrong
- Topics
- HER2/EGFR in Cancer Research (149 papers)Cancer Treatment and Pharmacology (138 papers)Breast Cancer Treatment Studies (130 papers)
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Norikazu Masuda
364 papers receiving 13.7k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Oncology 9.9k
- Pulmonary and Respiratory Medicine 7.0k
- Cancer Research 4.4k
- Molecular Biology 3.0k
- Genetics 1.7k
Countries citing papers authored by Norikazu Masuda
This map shows the geographic impact of Norikazu Masuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norikazu Masuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norikazu Masuda more than expected).
Fields of papers citing papers by Norikazu Masuda
This network shows the impact of papers produced by Norikazu Masuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norikazu Masuda. The network helps show where Norikazu Masuda may publish in the future.
Co-authorship network of co-authors of Norikazu Masuda
This figure shows the co-authorship network connecting the top 25 collaborators of Norikazu Masuda. A scholar is included among the top collaborators of Norikazu Masuda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norikazu Masuda. Norikazu Masuda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | 5 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 2 | |
| 7 | 54 | |
| 8 | Safety in Japanese Advanced Breast Cancer Patients Who Received Abemaciclib in MONARCH 2 and MONARCH 3: Assessment of Treatment-Emergent Neutropenia, Diarrhea, and Increased Alanine Aminotransferase and Aspartate Aminotransferase Levels | 8 |
| 9 | 9 | |
| 10 | 24 | |
| 11 | 1 | |
| 12 | 1 | |
| 13 | 5 | |
| 14 | 13 | |
| 15 | 18 | |
| 16 | 28 | |
| 17 | Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutationbreakdown → | 2156 |
| 18 | 13 | |
| 19 | 56 | |
| 20 | [Current status and future perspectives for the treatment of triple-negative breast cancer in Japan]. | 1 |
About Norikazu Masuda
Norikazu Masuda is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 389 papers that have together received 14.0k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (149 papers), Cancer Treatment and Pharmacology (138 papers) and Breast Cancer Treatment Studies (130 papers). The work is most often cited by research in Oncology (9.9k citations), Cancer Research (4.4k citations) and Pulmonary and Respiratory Medicine (7.0k citations). Norikazu Masuda has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Seock‐Ah Im, Hiroji Iwata, Pierfranco Conté, Binghe Xu, Mark E. Robson, Suzette Delaloge, Elżbieta Senkus, Anne Armstrong, Nadine Tung and Susan M. Domchek. Their work appears in journals such as New England Journal of Medicine, Nucleic Acids Research and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.